Cross-Scanner Prostate MRI CAD for Aggressive Cancer Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for diagnosing aggressive prostate cancer using MRI images are less reliable than human radiologists and are not robust across different types of MR scanners, leading to missed diagnoses or unnecessary aggressive treatments.

Innovation Solution

A system and method that utilize a control module to analyze MRI images of the prostate, calculating scores based on apparent diffusion coefficient and contrast agent wash-in/wash-out rates to identify aggressive cancer regions, using logistic regression to determine the presence of cancer, and providing diagnostic feedback to physicians.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If image processing methods are used to recognize signs of aggressive cancer in MRI images, then biopsy targeting is improved, but reliability decreases compared to experienced radiologists

Engineering Contradiction:
Improvebiopsy targetingVSAvoidcancer detection reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent introduces an intermediary system that combines multiple MRI sequences (T2-weighted, diffusion-weighted, dynamic contrast-enhanced) with automated image processing and radiomics analysis to bridge the gap between raw imaging data and reliable cancer detection, achieving radiologist-level or superior reliability while maintaining ease of operation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system performs multiple functions simultaneously: it processes multiple MRI sequences, extracts radiomics features, applies machine learning algorithms, and generates biopsy targeting recommendations, making it a universal solution that works across different scanner types and protocols

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Device complexity

If pre-existing image processing methods are developed using a limited number of MR scanners, then development complexity is reduced, but reliability decreases when used with different MR scanner types

Engineering Contradiction:
Improvesystem development complexityVSAvoidcross-scanner reliability
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The system changes parameters by incorporating data from multiple MRI sequences and adjusting radiomics feature extraction to account for variations in scanner types, magnetic field strengths, and imaging protocols, enabling reliable performance across diverse equipment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system performs preliminary actions by pre-processing and standardizing images from different scanners before analysis, applying normalization and calibration steps that prepare the data in advance to ensure consistent results across various hardware platforms

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP4330910B1System for helping diagnosing aggressive prostate cancers and related method
Publication Date: 2025.09.24 INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)
  • EP4330910B1 patent drawingFigure 1
  • EP4330910B1 patent drawingFigure 2
  • EP4330910B1 patent drawingFigure 3

AI summary

The invention relates to a system and a method for computer-aided detection (CAD) of aggressive prostate cancers. The automatic diagnosis of aggressive prostate cancers is difficult and methods that work with some MRI scanners do not work as well when implemented on images from different scanners. By studying a data base containing MRI data and biopsy results from 265 patients, acquired by 4 different types of MRI scanners, using machine learning techniques, the inventors established a method for automatically determining the presence of aggressive cancers, this methods showing high sensitivity and specificity when implemented on another database containing MRI data from 270 patients, acquired by different MRI scanners than the first database. The method involves feeding MRI images to a system calculating a score for a portion of the prostate and determines that the portion contains an aggressive cancer based on whether a criterion depending on the score is verified.